Alcon Withdraws Surgical Glaucoma Micro-Stent After New COMPASS Post-Analysis
August 29th 2018The COMPASS-XT five-year analysis reported that patients treated with the micro-stent experienced statistically significant loss of endothelial cells compared to the patients treated with lone cataract surgery.
Read More
FDA Approves Eravacycline for Complicated Intra-Abdominal Infections
August 28th 2018Relevant cIAI diagnoses include intra-abdominal abscess, stomach perforation, peritonitis, appendicitis, and more. Eravacycline's efficacy and safety were established in non-inferiority studies comparing it to the widely-used therapies ertapenem and meropenem.
Read More
Five-Year SCOT-HEART Update Indicates CTA Screening Reduces Heart Attack Deaths
August 25th 2018The update reported significant improvements in future cardiovascular risks in patients at risk for chronic angina initially referred for CTA plus standard care, versus those only referred to standard care.
Read More
FDA Approves Ivacaftor as First Therapy for Underlying Cause of Cystic Fibrosis in Young Children
August 16th 2018The approval is based on data from an ongoing phase 3 open-label safety study of 25 children with CF who have one of 10 mutations in the CFTR gene, in which ivacaftor demonstrated a consistent safety profile.
Read More
Retina Stem Cell Therapy Restores Vision in Animal Models
August 15th 2018In an effort to reprogram retina cell regeneration, investigators activated dormant stem cells then aided other stem cells in developing into rod photoreceptor cells—the most abundant cell type in the retina which first aid the retina in sensing light.
Read More
Q&A: Frank Chervenak, MD, on the Culture of Northwell Health
August 14th 2018Chervenak was recently appointed chair of the department of obstetrics and gynecology at Lenox Hill Hospital and chair of the academic department of obstetrics & gynecology and associate dean for international medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.
Read More
Hospitalization Due to Firearm Assault Nearly Eight-Fold in Urban Adolescents
August 10th 2018According to pooled data, 91.8% of the hospitalizations due to firearm injuries in pediatric and adolescent patients were of urban patients, 4.8% were of micropolitan patients, and 3.3% were of rural patients.
Read More
FDA Approves Methylphenidate PM Formulation for ADHD
August 9th 2018The novel methylphenidate formulation indicated for evening administration in patients with ADHD aged 6 years and older has shown improvement in the severity of ADHD symptoms in the early morning and throughout the day for patients.
Read More